CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 23 filers reported holding CANCER GENETICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $6,000 | -33.3% | 24,022 | -37.7% | 0.00% | 0.0% |
| Q4 2018 | $9,000 | -82.7% | 38,532 | -22.2% | 0.00% | -83.3% |
| Q3 2018 | $52,000 | +10.6% | 49,532 | -5.3% | 0.01% | 0.0% |
| Q2 2018 | $47,000 | -40.5% | 52,310 | +9.4% | 0.01% | -40.0% |
| Q1 2018 | $79,000 | -10.2% | 47,800 | 0.0% | 0.01% | -9.1% |
| Q4 2017 | $88,000 | -31.8% | 47,800 | 0.0% | 0.01% | -35.3% |
| Q3 2017 | $129,000 | -45.8% | 47,800 | -20.7% | 0.02% | -45.2% |
| Q2 2017 | $238,000 | -33.3% | 60,300 | -30.7% | 0.03% | -35.4% |
| Q1 2017 | $357,000 | +192.6% | 87,000 | -3.9% | 0.05% | +166.7% |
| Q4 2016 | $122,000 | – | 90,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Timpani Capital Management LLC | 206,579 | $2,847,000 | 1.42% |
| Sterneck Capital Management, LLC | 95,830 | $1,321,000 | 0.80% |
| PERKINS CAPITAL MANAGEMENT INC | 81,775 | $1,127,000 | 0.76% |
| GRUBER & MCBAINE CAPITAL MANAGEMENT LLC | 83,900 | $1,156,000 | 0.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 354,180 | $4,881,000 | 0.25% |
| WHITE PINE CAPITAL LLC | 54,350 | $748,000 | 0.14% |
| SSI INVESTMENT MANAGEMENT LLC | 62,959 | $868,000 | 0.08% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 151,214 | $2,084,000 | 0.08% |
| ROTHSCHILD INVESTMENT LLC /IL | 31,200 | $430,000 | 0.06% |
| ARDSLEY ADVISORY PARTNERS LP | 27,500 | $379,000 | 0.05% |